Skip to main content
NCBI home page
British Journal of Preventive & Social Medicine logoLink to British Journal of Preventive & Social Medicine
. 1976 Mar;30(1):40–53. doi: 10.1136/jech.30.1.40

Screening for spina bifida cystica. A cost-benefit analysis.

S Hagard, F Carter, R G Milne
PMCID: PMC478937  PMID: 59616

Abstract

The costs and economic benefits are examined of introducing a programme for the mass-screening of pregnancies for the detection and abortion of fetuses with spina bifida cystica. A benefit-cost index is derived, and the possible effects on it of making different input assumptions are discussed. It is considered that, on economic grounds, screening may be worthwhile only in populations in which the incidence of spina bifida is high.

Full text

PDF
40

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan L. D., Ferguson-Smith M. A., Donald I., Sweet E. M., Gibson A. A. Amniotic-fluid alpha-fetoprotein in the antenatal diagnosis of spina bifida. Lancet. 1973 Sep 8;2(7828):522–525. doi: 10.1016/s0140-6736(73)92347-7. [DOI] [PubMed] [Google Scholar]
  2. Bartsch F. K., Lundberg J., Wahlström J. The technique, results and risks of amniocentesis for genetic reasons. J Obstet Gynaecol Br Commonw. 1974 Dec;81(12):991–994. doi: 10.1111/j.1471-0528.1974.tb00420.x. [DOI] [PubMed] [Google Scholar]
  3. Beazley J. M., Underhill R. A. Confinement date unknown. Nurs Times. 1971 Nov 11;67(45):1414–1417. [PubMed] [Google Scholar]
  4. Brock D. J., Bolton A. E., Scrimgeour J. B. Prenatal diagnosis of spina bifida and anencephaly through maternal plasma-alpha-fetoprotein measurement. Lancet. 1974 Apr 27;1(7861):767–769. doi: 10.1016/s0140-6736(74)92839-6. [DOI] [PubMed] [Google Scholar]
  5. Chard T. The fetus at risk. Lancet. 1974 Oct 12;2(7885):880–883. doi: 10.1016/s0140-6736(74)91212-4. [DOI] [PubMed] [Google Scholar]
  6. Cochrane A. L., Holland W. W. Validation of screening procedures. Br Med Bull. 1971 Jan;27(1):3–8. doi: 10.1093/oxfordjournals.bmb.a070810. [DOI] [PubMed] [Google Scholar]
  7. EDWARDS J. H. Congenital malformations of the central nervous system in Scotland. Br J Prev Soc Med. 1958 Jul;12(3):115–130. doi: 10.1136/jech.12.3.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Elwood J. H. Major central nervous system malformations notified in Northern Ireland 1964-1968. Dev Med Child Neurol. 1972 Dec;14(6):731–739. doi: 10.1111/j.1469-8749.1972.tb03316.x. [DOI] [PubMed] [Google Scholar]
  9. Evans K., Hickman V., Carter C. O. Handicap and social status of adults with spina bifida cystica. Br J Prev Soc Med. 1974 May;28(2):85–92. doi: 10.1136/jech.28.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Freeston B. M. An enquiry into the effect of a spina bifida child upon family life. Dev Med Child Neurol. 1971 Aug;13(4):456–461. doi: 10.1111/j.1469-8749.1971.tb03052.x. [DOI] [PubMed] [Google Scholar]
  11. Hare E. H., Laurence K. M., Payne H., Rawnsley K. Spina bifida cystica and family stress. Br Med J. 1966 Sep 24;2(5516):757–760. doi: 10.1136/bmj.2.5516.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hunt G. M. Implications of the treatment of myelomeningocele for the child and his family. Lancet. 1973 Dec 8;2(7841):1308–1310. doi: 10.1016/s0140-6736(73)92881-x. [DOI] [PubMed] [Google Scholar]
  13. Jones W. T., Grahame H. Research in health education. Br Med Bull. 1974 Sep;30(3):276–281. doi: 10.1093/oxfordjournals.bmb.a071215. [DOI] [PubMed] [Google Scholar]
  14. Leek A. E., Ruoss C. F., Kitau M. J., Chard T. Raised alpha-fetoprotein in maternal serum with anencephalic pregnancy. Lancet. 1973 Aug 18;2(7825):385–385. doi: 10.1016/s0140-6736(73)93236-4. [DOI] [PubMed] [Google Scholar]
  15. Lightowler C. D. Meningomyelocele: the price of treatment. Br Med J. 1971 May 15;2(5758):385–387. doi: 10.1136/bmj.2.5758.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Dev Med Child Neurol. 1971 Jun;13(3):279–303. [PubMed] [Google Scholar]
  17. McKinlay J. B. The new late comers for antenatal care. Br J Prev Soc Med. 1970 Feb;24(1):52–57. doi: 10.1136/jech.24.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nevin N. C., Nesbitt S., Thompson W. Myelocele and alpha-fetoprotein in amniotic fluid. Lancet. 1973 Jun 16;1(7816):1383–1383. doi: 10.1016/s0140-6736(73)91699-1. [DOI] [PubMed] [Google Scholar]
  19. Richards I. D., McIntosh H. T. Spina bifida survivors and their parents: a study of problems and services. Dev Med Child Neurol. 1973 Jun;15(3):292–304. [PubMed] [Google Scholar]
  20. Richards I. D., McIntosh H. T., Sweenie S. A genetic study of anencephaly and spina bifida in Glasgow. Dev Med Child Neurol. 1972 Oct;14(5):626–639. doi: 10.1111/j.1469-8749.1972.tb02645.x. [DOI] [PubMed] [Google Scholar]
  21. Smith G. K., Smith E. D. Selection for treatment in spina bifida cystica. Br Med J. 1973 Oct 27;4(5886):189–197. doi: 10.1136/bmj.4.5886.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stark G. D., Drummond M. Results of selective early operation in myelomeningocele. Arch Dis Child. 1973 Sep;48(9):676–683. doi: 10.1136/adc.48.9.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wald N. J., Brock D. J., Bonnar J. Prenatal diagnosis of spina bifida and anencephaly by maternal serum-alpha-fetoprotein measurement. A controlled study. Lancet. 1974 Apr 27;1(7861):765–767. doi: 10.1016/s0140-6736(74)92838-4. [DOI] [PubMed] [Google Scholar]
  24. Walker J. H., Thomas M., Russell I. T. Spina bifida--and the parents. Dev Med Child Neurol. 1971 Aug;13(4):462–476. doi: 10.1111/j.1469-8749.1971.tb03053.x. [DOI] [PubMed] [Google Scholar]

Articles from British journal of preventive & social medicine are provided here courtesy of BMJ Publishing Group

RESOURCES